2nd Jul 2020 13:12
Ap19
FORM 8.3 - Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 30 June 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,393,183 | 1.08% | 454,224 | 0.35% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
333,000 | 0.26% | 383,659 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,726,183 | 1.34% | 837,883 | 0.65% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 12 | 195.3233 USD |
| Purchase | 15 | 195.9600 USD |
| Purchase | 15 | 195.9200 USD |
| Purchase | 77 | 191.6000 USD |
| Purchase | 100 | 197.6050 USD |
| Purchase | 100 | 196.9300 USD |
| Purchase | 200 | 194.2598 USD |
| Purchase | 200 | 194.8800 USD |
| Purchase | 201 | 195.5926 USD |
| Purchase | 300 | 194.2333 USD |
| Purchase | 353 | 196.9163 USD |
| Purchase | 380 | 195.7846 USD |
| Purchase | 1,130 | 196.6954 USD |
| Purchase | 1,168 | 196.8935 USD |
| Purchase | 3,787 | 196.3492 USD |
| Purchase | 5,434 | 194.4886 USD |
| Purchase | 5,930 | 195.6760 USD |
| Purchase | 9,162 | 196.9500 USD |
| Purchase | 13,124 | 195.8133 USD |
| Purchase | 96,770 | 196.0567 USD |
| Sale | 1 | 191.3000 USD |
| Sale | 3 | 195.2433 USD |
| Sale | 4 | 196.7900 USD |
| Sale | 8 | 196.7700 USD |
| Sale | 8 | 196.6050 USD |
| Sale | 8 | 196.1700 USD |
| Sale | 8 | 196.5300 USD |
| Sale | 9 | 195.3500 USD |
| Sale | 10 | 195.0400 USD |
| Sale | 12 | 196.5200 USD |
| Sale | 14 | 196.8771 USD |
| Sale | 28 | 196.6714 USD |
| Sale | 30 | 195.9200 USD |
| Sale | 36 | 196.5088 USD |
| Sale | 39 | 196.7130 USD |
| Sale | 61 | 195.6900 USD |
| Sale | 100 | 193.4300 USD |
| Sale | 100 | 194.9800 USD |
| Sale | 100 | 195.5000 USD |
| Sale | 100 | 195.6550 USD |
| Sale | 100 | 196.2800 USD |
| Sale | 100 | 196.9507 USD |
| Sale | 130 | 193.8165 USD |
| Sale | 175 | 195.9614 USD |
| Sale | 200 | 194.8800 USD |
| Sale | 200 | 196.5800 USD |
| Sale | 239 | 196.4956 USD |
| Sale | 260 | 195.3596 USD |
| Sale | 330 | 194.2034 USD |
| Sale | 362 | 196.3113 USD |
| Sale | 1,100 | 196.7715 USD |
| Sale | 1,168 | 196.8935 USD |
| Sale | 1,453 | 195.9615 USD |
| Sale | 2,233 | 195.1793 USD |
| Sale | 2,324 | 196.5774 USD |
| Sale | 2,600 | 195.8032 USD |
| Sale | 2,730 | 196.0192 USD |
| Sale | 3,300 | 195.6333 USD |
| Sale | 3,448 | 196.1871 USD |
| Sale | 3,702 | 194.1855 USD |
| Sale | 3,710 | 196.0214 USD |
| Sale | 4,300 | 195.5458 USD |
| Sale | 5,653 | 196.1432 USD |
| Sale | 5,872 | 196.1926 USD |
| Sale | 6,703 | 196.0493 USD |
| Sale | 8,032 | 196.2865 USD |
| Sale | 10,432 | 196.9500 USD |
| Sale | 10,818 | 196.2987 USD |
| Sale | 13,411 | 195.8225 USD |
| Sale | 43,591 | 195.9764 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 2 Jul 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200702005268/en/
Copyright Business Wire 2020
Related Shares:
Barclays